Haloperidol (CAS 52-86-8) Global Market Research Report 2024

About the Haloperidol Market

Haloperidol is a drug used to treat schizophrenia, a mental disorder characterized by delusions, hallucinations, and disorganized thinking. It is a type of antipsychotic medication that works by blocking dopamine receptors in the brain, reducing the symptoms of schizophrenia. Haloperidol is available in both oral and injectable forms, and is often used in combination with other antipsychotic medications. It is generally well-tolerated, but can cause side effects such as drowsiness, restlessness, and muscle spasms. Haloperidol is one of the most commonly prescribed antipsychotic medications, and is widely used in the treatment of schizophrenia. It is available in generic form, as well as under brand names such as Haldol, Serenace, and Serenace Depot. It is also used off-label to treat a variety of conditions, including Tourette's syndrome, bipolar disorder, and severe behavioral problems in children. The market for haloperidol is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Pfizer, Novartis, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more